GlaxoSmithKline lung drug Anoro approved in Europe
May 08, 2014 at 11:21 AM EDT
LONDON, May 8 (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise.
